CLINTON WALKER: Open Payments
NPI 1124417761 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 19 payments from 11 companies in 2025. Trend: 2023 $616 · 2024 $600 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $118 |
| CSL Behring | 3 | $74 |
| Biogen, Inc. | 3 | $72 |
| Alexion Pharmaceuticals, Inc. | 2 | $64 |
| Sarepta Therapeutics, Inc. | 1 | $31 |
| ARGENX US, INC. | 1 | $27 |
| ABBVIE INC. | 1 | $26 |
| Merz Pharmaceuticals, LLC | 1 | $23 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
Products named: Hizentra, ULTOMIRIS, Fintepla, Zilbrysq, SPINRAZA, Elevidys, VYVGART HYTRULO, BOTOX.
Industry payments across MS — which companies pay providers there.
